Formerly MindMed, it develops an LSD-based pill for anxiety.
New: first time
Duquesne bought Definium Therapeutics for the first time between April and June: 356,600 shares, worth about $17 million. That’s already less than $1 of every $100 they have in stocks.
Mar 31
None
Jun 30
356,600
The numbers
Shares they own
356,600
Value on Jun 30, 2026
$16,774,000
about $17 million
Share of their money
0.4%
less than $1 of every $100 · 52nd of 85
Price per share on Jun 30
$47.04
Kind
Shares
Also owned by
No other fund we follow
More about Definium Therapeutics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.